Untitled Document

BSP - Biological Signal Processing Ltd.

What's New


BSP
is dedicated to providing novel, non-invasive and highly reliable solutions for the diagnosis and monitoring of Ischemic Heart Disease. 
 

Using proprietary signal processing technology, the HyperQ™ EX-300 Stress System performs analysis of the high-frequency QRS components for more sensitive and accurate results than conventional stress testing.

Integration of BSP's innovative technology into our top-of-the-line stress ECG system enables a unique solution providing superior diagnostic accuracy, while utilizing conventional stress testing protocols.


July 1, 2010

Eurostars approval for BSP-Schiller new project for development of novel products based on BSP's HyperQ technology


June 15, 2010

Nissim Greisas appointed CEO of BSP

March 14, 2010

Outstanding results on improved detection of ischemic heart disease in women presented in the ACC conference in Atlanta


April 13, 2010

First installations of BSP and Schiller's integrated system

November 17, 2009

Schiller launches a stress ECG system with BSP's HyperQ analyzer in Medica


February 11, 2010

BSP completes a private funding round in the amount of US $ 1.7
Million and submits prospectus to TASE

Untitled Document